Keyphrases
Chemotherapy-induced Peripheral Neuropathy
100%
Neuropathy
55%
Multicenter Randomized Controlled Trial
50%
Frozen Gloves
50%
Quality of Life Impact
50%
Tolerability
50%
Quality of Life
40%
Tingling
35%
Confidence Interval
30%
Tailored Treatment
25%
Treatment Plan
25%
Multiple Myeloma
25%
Healthcare Quality Improvement
25%
Patient Identification
25%
Colon Cancer
25%
Total Dose
25%
EORTC QLQ-CIPN20
10%
Quality of Life Improvement
10%
Chemotherapy
10%
Starting Treatment
5%
Docetaxel
5%
Oxaliplatin
5%
Intention-to-treat Analysis
5%
QLQ-C30
5%
Colorectal Cancer
5%
Cramps
5%
Oncology Department
5%
End of Treatment
5%
Breast Cancer
5%
Both Hands
5%
INIS
chemotherapy
100%
patients
90%
quality of life
75%
side effects
50%
gloves
50%
hands
44%
symptoms
35%
people
30%
cancer
25%
doses
15%
fingers
15%
control
15%
monitoring
10%
colon
10%
risks
10%
limbs
5%
breasts
5%
pain
5%
comparative evaluations
5%
losses
5%
hypothermia
5%
reduction
5%
interventions
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy-Induced Peripheral Neuropathy
100%
Randomized Controlled Trial
50%
Side Effect
50%
Tolerability
50%
Neuropathy
43%
Chemotherapy
20%
Malignant Neoplasm
20%
Multiple Myeloma
16%
Colon Carcinoma
16%
Breast Cancer
10%
Hypothermia
10%
Muscle Cramp
10%
Docetaxel
10%
Oxaliplatin
10%
Paclitaxel
10%
Colorectal Carcinoma
10%
